Your session is about to expire
← Back to Search
Study Summary
This trial aims to study how the body processes and eliminates a drug called ABBV-552 in healthy men after they take a single dose by mouth.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Which individuals meet the criteria for eligibility to take part in this research investigation?
"This study aims to enroll 8 participants aged between 18 and 55 who are currently without any known medical conditions. Specifically, male volunteers in overall good health will be considered during the screening process."
What are the safety considerations associated with ABBV-552 in individuals?
"Based on the current Phase 1 trial status with limited safety and efficacy data, ABBV-552 received a safety rating of 1 from our team at Power."
What is the total number of participants being recruited for this research endeavor?
"Yes, information from clinicaltrials.gov indicates that this study is currently seeking participants. It was first listed on 2/21/2024 and last modified on 2/29/2024. The trial aims to enroll 8 patients at a single site."
Are individuals aged 70 and above being recruited for this research study?
"Recruitment for this study is targeting individuals above 18 years old but below the age of 55."
Are there any available slots for patients to participate in this research study?
"Indeed, the details on clinicaltrials.gov indicate an ongoing search for suitable candidates for this investigation. The trial was first listed on February 21st, 2024 and most recently revised on February 29th, 2024. Enrollment is open to a total of 8 participants across one designated site."
Share this study with friends
Copy Link
Messenger